A 385358
CAS No. 406228-55-5
A 385358 ( A385358 )
Catalog No. M14400 CAS No. 406228-55-5
A 385358 is a potent, selective, cell-permeable Bcl-XL inhibitor with Ki of 0.8 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 176 | Get Quote |
|
10MG | 266 | Get Quote |
|
25MG | 461 | Get Quote |
|
50MG | 669 | Get Quote |
|
100MG | 945 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameA 385358
-
NoteResearch use only, not for human use.
-
Brief DescriptionA 385358 is a potent, selective, cell-permeable Bcl-XL inhibitor with Ki of 0.8 nM.
-
DescriptionA 385358 is a potent, selective, cell-permeable Bcl-XL inhibitor with Ki of 0.8 nM, displays >80-fold selectivity over Bcl-2 (Ki=64 nM); shows relatively modest single-agent cytotoxic activity against most tumor cell lines with an EC50 of <500 nM in cells dependent on Bcl-X(L) for survival; enhances the in vitro cytotoxic activity of numerous chemotherapeutic agents; significantly inhibits tumor growth in the A549 xenograft model.
-
SynonymsA385358
-
PathwayAngiogenesis
-
TargetBcl-2
-
RecptorBcl-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number406228-55-5
-
Formula Weight639.83
-
Molecular FormulaC32H41N5O5S2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 125 mg/mL195.36 mM
-
SMILESO=C(NS(=O)(C1=CC=C(N[C@H](CCN(C)C)CSC2=CC=CC=C2)C([N+]([O-])=O)=C1)=O)C3=CC=C(N4CCC(C)(C)CC4)C=C3
-
Chemical NameN-[4-[[(2R)-4-(Dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-(4,4-dimethylpiperidin-1-yl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wendt MD, et al. J Med Chem. 2006 Feb 9;49(3):1165-81.
2. Shoemaker AR, et al. Cancer Res. 2006 Sep 1;66(17):8731-9.
2. Shoemaker AR, et al. Cancer Res. 2006 Sep 1;66(17):8731-9.
molnova catalog
related products
-
SMBA1
A potent, and selective Bax agonist (Ki=43.3 nM) that induces conformational changes in Bax by blocking S184 phosphorylation.
-
Orobol
Orobol is an inhibitor of tyrosine-specific protein kinase and phosphatidylinositol turnover. Orobol inhibits PI3K isoforms with IC50s of 3.46-5.27 μM for PI3K α/β/γ/K/δ. Orobol exhibits anti-skin-aging and anti-obesity effects.
-
BDA-366
A potent, selective Bcl2 BH4 domain antagonist with Ki of 3.3 nM; shows no affinity for other Bcl2 family members, including Bcl-XL, Mcl-1, or Bfl-1/A1.